Inhibition of 7-dehydrocholesterol reductase by the teratogen AY9944: A rat model for Smith-Lemli-Opitz syndrome

Teratology

Volumn 54, Issue 3, 1996, Pages 115-125

  Kolf Clauw, M ^a   Chevy, F ^b   Wolf, C ^b   Siliart, B ^c   Citadelle, D ^b   Roux, C ^b  

^a ECOLE NATIONALE VÉTÉRINAIRE D ALFORT   (France)

^b HÔPITAL SAINT ANTOINE   (France)

^c LUNAM UNIVERSITÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 BIS(2 CHLOROBENZYLAMINOMETHYL)CYCLOHEXANE; 7 DEHYDROCHOLESTEROL; CHOLESTEROL; OXIDOREDUCTASE; PROGESTERONE; STEROID HORMONE; STEROL; TERATOGENIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLESTEROL METABOLISM; CONTROLLED STUDY; ENZYMATIC ASSAY; ENZYME INHIBITION; FACE DYSMORPHIA; GAS CHROMATOGRAPHY; HOLOPROSENCEPHALY; HYPOCHOLESTEROLEMIA; HYPOPHYSIS DISEASE; KINETICS; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; RAT; REDUCTION; SMITH LEMLI OPITZ SYNDROME;

ANIMALS; CHOLESTEROL; DISEASE MODELS, ANIMAL; ESTRADIOL; OXIDOREDUCTASES; OXIDOREDUCTASES ACTING ON CH-CH GROUP DONORS; PROGESTERONE; RATS; RATS, WISTAR; SMITH-LEMLI-OPITZ SYNDROME; TERATOGENS; TRANS-1,4-BIS(2-CHLOROBENZAMINOMETHYL)CYCLOHEXANE DIHYDROCHLORIDE;

ANIMALIA;

EID: 12644317830     PISSN: 00403709     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9926(199609)54:3<115::AID-TERA1>3.0.CO;2-2     Document Type: Article

References (53)

1. Abuelo, D.N., G.S. Tint, R. Kelley, A.K. Batte, S. Shefer, and G. Salen (1995) Prenatal detection of the cholesterol biosynthetic defect in the Smith-Lemli-Opitz syndrome by the analysis of amniotic fluid sterols. Am. J. Med. Genet., 56:281-285.
2. Albrecht, E.D. (1985) Pregnancy in young and aged rats. II. Peripheral serum progesterone concentrations. Biol. Reprod., 33:432-435.
3. 7-reductase, on cholesterol biosynthesis in primary rat hepatocytes. Biochem. Pharmacol., 35:911-916.
4. Axelson, M. (1991) Occurrence of isomeric dehydrocholesterols in human plasma. J. Lipid Res., 32:1441-1448.
5. Barbu, V., C. Roux, R. Dupuis, J. Gardette, and J.-C. Mazière (1984) Teratogenic effect of AY9944 in rats: Importance of the day of administration and maternal plasma cholesterol level. Proc. Soc. Exp. Biol. Med., 776:54-59.
6. Barbu, V., C. Roux, D. Lambert, R. Dupuis, J. Gardette, J.-C. Mazière, C. Mazière, E. Elefant, and J. Polonovski (1988) Cholesterol prevents the teratogenic action of AY 9944: Importance of the timing of cholesterol supplementation to rats. J. Nutr., 778:774-779.
7. Batta, A.K., G.S. Tint, S. Shefer, D. Abuelo, and G. Salen (1995a) Identification of 8-dehydrocholesterol in patients with Smith-Lemli-Opitz syndrome. J. Lipid Res., 36:705-713.
8. Batta, A.K., G. Salen, G.S. Tint, and S. Shefer (1995b) Identification of 19-nor 5,7,9(10)-cholestatrien-3β-ol in patients with Smith-Lemli-Opitz syndrome. J. Lipid Res., 36:2413-2418.
9. Beato, M. (1989) Gene regulation by steroid hormones. Cell, 56:335-344.
10. Chasalow, F.I., S.L. Blethen, and K. Taysi (1985) Possible abnormalities of steroid secretion in children with Smith-Lemli-Opitz syndrome and their parents. Steroids, 46:827-843.
11. DeMeyer, W., W. Zeman, and C.G. Palmer (1964) The face predicts the brain: Diagnostic significance of median facial anomalies for holoprosencephaly (arhinencephaly). Pediatrics, 34:256-263.
12. Donnai O., I.D. Young, W.G. Owen, S.A. Clark, F.W. Miller, and W.F. Knox (1986) The lethal multiple congenital anomaly syndrome of polydactyly, sex reversal renae hypoploria, and unilobular lungs. J. Med. Genet. 23:64-71.
13. 7-reductase, on serum and tissue lipids in the rat. J. Lipid Res., 9:587-595.
14. Elias, D., H. Kawamoto, and L. Wilson (1992) Holoprosencephaly and midline facial anomalies: Redefining classification and management. Plast. Reconstr. Surg., 90:951-958.
15. Folch, J., M. Lees, and G.H.S. Sloane Stanly (1957) A simple method for the isolation and purification to total steroids from animal tissues. J. Biol. Chem., 226:497-509.
16. Forcelledo, M.L., R. Vera, and H.B. Croxatto (1981) Ovum transport in pregnant, pseudopregnant, and cyclic rats and its relationship to estradiol and progesterone blood levels. Biol. Reprod., 24:760-765.
17. Fuentealba, B., M. Nieto, and H.B. Croxatto (1987) Ovum transport in pregnant rats is little affected by RU486 and exogenous progesterone as compared to cycling rats. Biol. Reprod., 37:768-774.
18. Fumagalli, R., M.E. Smith, G. Urna, and R. Paoletti (1969) The effect of hypocholesteremic agents on myelinogenesis. J. Neurochem., 16: 1329-1339.
19. Fumagalli, R., F. Bernini, G. Galli, M. Anastasia, and A. Fiecci (1980) The identification of a novel C27 diene, cholesta 5,dien-3β-ol, in tissues of rats given AY-9944 (trans-1,4-bis(2-dichlorobenzylaminoethyl)cyclohexane) in pregnancy. Steroids, 55:665-672.
20. 4-isomerase (3β-HSD), is expressed in rat brain. Mol. Brain Res., 30:287-300.
21. Homanics, G.E., N. Maeda, M.G. Traber, H.J. Kayden, D.B. Dehart, and K.K. Sulik (1995) Exencephaly and hydrocephaly in mice with targeted modification of the apolipoprotein B (Apob) gene. Teratology, 51:1-10.
22. Honda, A., G.S. Tint, G. Salen, A.K. Batta, T.S. Chen, and S. Shefer (1995) Defective conversion of 7-dehydrocholesterol to cholesterol in cultured skin fibroblasts from Smith-Lemli-Opitz syndrome homozygotes. J. Lipid Res., 36:1595-1601.
23. Irons, M., E.R. Elias, G.S. Tint, G. Salen, R. Frieden, T.M. Buie, and M. Ampola (1994) Abnormal cholesterol metabolism in the Smith-Lemli-Opitz syndrome: Report of clinical and biochemical findings in four patients and treatment in one patient. Am. J. Med. Genet., 50:347-352.
24. Kelley, R.I. (1995) Diagnosis of Smith-Lemli-Opitz syndrome by gas chromatography/mass spectrometry of 7-dehydrocholesterol in plasma, amniotic fluid and cultured skin fibroblasts. Clin. Chim. Acta, 236:45-58.
25. Khera, K.S. (1987) Maternal toxicity of drugs and metabolic disorders - A possible etiologic factor in the intrauterine death and congenital malformation: A critique on human data. CRC Crit. Rev. Toxicol., 17:345-375.
26. Koenig, H.L., M. Schumacher, B. Ferzaz, A.N. Do Thi, A. Ressouches, R. Guennoun, I. Jung-Testas, P. Robel, Y. Akwa, and E.-E. Baulieu (1995) Progesterone synthesis and myelin formation by Schwann cells. Science, 268:1500-1503.
27. Kraml, M., J.F. Gagli, and D. Dvornik (1964) Inhibition of the conversion of 7-dehydrocholesterol to cholesterol by AY9944. Biochem. Biophys. Res. Commun., 15:455-457.
28. Marton, A.V., E. Greselin, M. Givner, and K. Voith (1964) Effect of a novel hypocholesterolemicagent,trans-1,4-bis-(2-chlorobenzylaminomethyl)cyclohexane dihydrochloride (AY9944) on adrenal morphology. Endocrinology, 75:469-476.
29. McKeever, P.A., and I.D. Young (1990) Smith-Lemli-Opitz syndrome II: A disorder of the fetal adrenals? J. Med. Genet., 27:465-466.
30. Minsker, D.H., J.S. Macdonald, R.T. Robertson, and D.L. Bokelman (1983) Mevalonate supplementation in pregnant rats suppresses the teratogenicity of mevinolinic acid, an inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A reductase. Teratology, 25:449-456.
31. Opitz, J. (1994) RSH/SLO ("Smith-Lemli-Opitz") syndrome: Historical, genetic, and developmental considerations. Am. J. Med. Genet., 50:344-346.
32. Opitz, J.M., and F. de la Cruz (1994) Cholesterol metabolism in the RSH/Smith-Lemli-Opitz syndrome: Summary of an NICHD conference. Am. J. Med. Genet., 50:326-338.
33. Pascalon, A., and M. Bertrand (1991) Hormone profiles during the oestrus cycle, pregnancy and pseudopregnancy in rats. Sci. Tech. Anim. Lab., 16:47-65.
34. Pepe, G., and I. Rotchild (1974) A comparative study of serum progesterone levels in pregnancy and in various types of pseudopregnancy in the rat. Endocrinology, 95:275-279.
35. Pill, J., H.F. Schmidt, K. Stegmeier, and E.C. Witte (1985) Effects of BM 15.766 on serum lipids in rats. Horm. Metab. Res., 17:543-544.
36. Repetto, M., J.C. Mazière, D. Citadelle, R. Dupuis, M. Meier, S. Biade, D. Quiec, and C. Roux (1990) Teratogenic effect of the cholesterol synthesis inhibitor AY 9944 on rat embryos in vitro. Teratology, 42:611-618.
37. Richmond, W. (1973) Preparation and properties of a cholesterol oxidase from Nocardia sp. and its application to the enzymatic assay of total cholesterol in serum. Clin. Chem., 79:1350-1355.
38. Rossiter, J.P., K.J. Hofman, and R.I. Kelley (1995) Smith-Lemli-Opitz syndrome: Prenatal diagnosis by quantification of cholesterol precursors in amniotic fluid. Am. J. Med. Genet., 56:272-275.
39. Roux, C. (1964) Action tératogène du triparanol chez l'animal. Arch. Fr. Pediatr., 21:451-464.
40. Roux, C., and M.M. Aubry (1966) Action tératogène chez le rat d'un inhibiteur de la synthèse du cholesterol, le AY 9944. C. R. Séances Soc. Biol., 160:1353-1357.
41. Roux, C., and C. Wolf (1995) Dysmetabolism of cholesterol and malformations. Second Conference on Medicine and Reproductive Biology: Prenatal Diagnosis, Hopital St. Antoine, Paris, June 24.
42. Roux, C., R. Dupuis, C. Horvath, and A. Giroud (1979a) Interpretation of isolated agenesia of the pituitary. Teratology, 19:39-44.
43. Roux, C., C. Horvath, and R. Dupuis (1979b) Teratogenic action and embryolethality of AY9944: Prevention by a hypercholesterolemia provoking diet. Teratology, 19:35-38.
44. Roux, C., R. Dupuis, C. Horvath, and J.-N. Talbot (1980) Teratogenic effect of an inhibitor of cholesterol synthesis (AY 9944) in rats: Correlation with maternal cholesterolemia. J. Nutr., 110:2310-2312.
45. Sarkar, C.P., and R.J. Cenedella (1982) Reactivity of key metabolic sterols in standard colorimetric assays for cholesterol. Lipids, 17: 46-49.
46. Schagina, L.V., Y.E. Korchev, A.E. Grinfeldt, A.A. Lev, and K. Blaskò (1992) Sterol specific inactivation of gramicidin A induced membrane cation permeability. Biochim. Biophys. Acta, 1109:91-96.
47. Smith, D.W., L. Lemli, and J.M. Opitz (1964) A newly recognized syndrome of multiple congenital anomalies. J. Pediatr., 64:210-217.
48. Tint, G.S. (1993) Cholesterol defect in Smith-Lemli-Opitz syndrome (letter to the editor). Am. J. Med. Genet., 47:573-574.
49. Tint, G.S., M. Irons, E.R. Elias, A.K. Batta, R. Frieden, T.S. Chen, and G. Salen (1994) Defective cholesterol biosynthesis associated with the Smith-Lemli-Opitz syndrome. N. Engl. J. Med., 330:107-113.
50. Tint, G.S., M. Seller, R. Hugues-Benzie, A.K. Batta, S. Shefer, D. Genest, M. Irons, E. Elias, and G. Salen (1995) Markedly increased tissue concentrations of 7-dehydrocholesterol combined with low levels of cholesterol are characteristic of the Smith-Lemli-Opitz syndrome. J. Lipid Res., 36:89-95.
51. Wiseman, H. (1993) Vitamin D is a membrane antioxidant. Ability to inhibit iron-dependent lipid peroxidation in liposomes compared to cholesterol, ergosterol and tamoxifen and relevance to anticancer action. FEBS Lett. 326:265-288.
52. Wu, J.T., and Z. Dickman (1971) Unilateral ovariectomy during early pregnancy in rat: No effect on embryonic survival. Endocrinology, 85:257-259.
53. Xu, G., G. Salen, S. Shefer, G.C. Ness, T.S. Chen, Z. Zhao, and G.S. Tint (1995) Reproducing abnormal cholesterol biosynthesis as seen in the Smith-Lemli-Opitz syndrome by inhibiting the conversion of 7-dehydrocholesterol to cholesterol in rats. J. Clin. Invest., 95:76-81.